<DOC>
	<DOCNO>NCT01604642</DOCNO>
	<brief_summary>The goal investigator study investigate role hormone name Activin A ( ActA ) development skeletal muscle atrophy cause cancer . According investigator hypothesis , ActA could release tumor activate muscle atrophy gene program . To answer question , investigator plan first compare circulating level ActA cancer patient without cachexia . In second step , investigator would like ass whether ActA circulate level predictive development cachexia short survival .</brief_summary>
	<brief_title>Role Activin A ( ActA ) Human Cancer Cachexia</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>18yearold old Colorectal lung cancer demonstrate histology cytology New diagnosis new recurrence Expected survival 3 month No previous history cancer last 5 year No pregnancy lactation Signed informed consent Noncaucasian Major digestive malabsorption Major depression Artificial nutrition Height dose steroid ( &gt; 1 mg/kg hydrocortisone equivalent ) Hyperthyroidism Other cause malnutrition Expected survival less 3 month Severely impair walk Anticoagulants antiplatelet therapy Disability medical condition might prevent compliance protocol Any condition may prevent compliance protocol Performance status ECOG &gt; ou = 4 Participation clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>